Effect of Daratumumab combined with Chemotherapy on Immune Function in Patients with Relapsed/Refractory Multiple Myeloma and Observation of its Clinical Efficacy.

Zhang, Ye-Hua; Xu, Feng; Xu, Chang-Qing; Zhang, Zi-Tan; Jiao, Zong-Jiu

Zhang, Ye-Hua; Xu, Feng; Xu, Chang-Qing; Zhang, Zi-Tan; Jiao, Zong-Jiu.

Afiliação

Zhang YH; Ye-hua Zhang, Department of Hematology, Xingtai People's Hospital, Xingtai 054001, Hebei, China.
Xu F; Feng Xu, Department of Hematology, Xingtai People's Hospital, Xingtai 054001, Hebei, China.
Xu CQ; Chang-qing Xu, Department of Hematology, Xingtai Third Hospital, Xingtai 054000, Hebei, China.
Zhang ZT; Zi-tan Zhang, Department of Hematology, Xingtai People's Hospital, Xingtai 054001, Hebei, China.
Jiao ZJ; Zong-jiu Jiao, Department of Hematology, Xingtai People's Hospital, Xingtai 054001, Hebei, China.

Pak J Med Sci ; 39(1): 248-252, 2023.

Article em En | MEDLINE | ID: mdl-36694744

Palavras-chave

Daratumumab; Immune function; Relapsed/Refractory multiple myeloma; Treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pak J Med Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google